A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: procedure (650), etiquette (1), practice (609)

Vinorelbine (oral day 1 and 8)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Oral) (Day 1 and 8) This protocol may require funding Regimen NSCLC
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineoralday1and8ver11.pdf

Atezolizumab

Description
Chemotherapy Protocol LUNG CANCER Atezolizumab Regimen • Lung – Atezolizumab Indication • Atezolizumab is indicated for treating previously platinum-treated locally advanced/ metastatic non
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Atezolizumab.pdf

Tivozanib

Description
Chemotherapy Protocol RENAL CELL Regimen TIVOZANIB • Renal Cell - Tivozanib Indication • Patients with a confirmed histological diagnosis of renal cell carcinoma with
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Tivozanib.pdf

InP cytarabine methotrexate

Description
Chemotherapy Protocol LYMPHOMA CYTARABINE-METHOTREXATE Inpatient Regimen Regimen • Lymphoma – InP-Cytarabine-Methotrexate Indication • Non-Hodgkin’s Lymphoma (CNS disease) Toxicity Drug
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-cytarabine-methotrexate.pdf

Brentuximab vedotin

Description
Chemotherapy Protocol LYMPHOMA BRENTUXIMAB VEDOTIN This protocol may require funding Regimen • Lymphoma – Brentuximab vedotin Indication • Hodgkin’s lymphoma • Systemic anaplastic large
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Brentuximab-vedotin.pdf

ABVD – Bleomycin-Dacarbazine-Doxorubicin-Vinblastine Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA BLEOMYCIN-DACARBAZINE-DOXORUBICIN-VINBLASTINE (ABVD) Regimen Lymphoma – ABVD-Bleomycin-Dacarbazine-Doxorubicin-Vinblastine Indication Hodgkin’s Lymphoma Toxicity Drug
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/ABVD-–-Bleomycin-Dacarbazine-Doxorubicin-Vinblastine-Ver-1.2.pdf

Cyclophosphamide-Doxorubicin-Paclitaxel

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOXORUBICIN-PACLITAXEL (21 day) Regimen • Breast Cancer – Cyclophosphamide-Doxorubicin-Paclitaxel (21 day) Indication • Neoadjuvant / adjuvant therapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Doxorubicin-Paclitaxel.pdf

Capecitabine-Lapatinib

Description
Chemotherapy Protocol BREAST CANCER CAPECITABINE-LAPATINIB This protocol may require funding Regimen • Breast Cancer – Capecitabine-Lapatinib Indication • Treatment of locally advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CapecitabineLapatinib.pdf

Cytarabine_2000_FludarabineIdarubicin_FLA-Ida

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (2000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (2000
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-2000-FludarabineIdarubicin-FLA-Ida.pdf

Cytarabine_1000_FludarabineIdarubicin_FLA-Ida

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (1000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (1000
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-1000-FludarabineIdarubicin-FLA-Ida.pdf
221 to 230 of 698
Previous … 21 22 23 24 25 … Next